ICON recently increased its expectations for earnings this year. The 2008 earnings per diluted share rose from $1.27 to $1.29, up from $1.23 to $1.26.
ICON CEO Peter Gray had this to say about the increase in earnings:
“For 2008 overall, we expect to report revenues in the range of $862 to $865 million, which is a modest reduction in previous guidance reflecting the impact of currency volatility over the last six months.”
This comes at a time when most CROs are lowing their profit and revenue outlooks. For more, read the article at Clinical Trials Today.
About:
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is an extension of the Partnerships in Clinical Trials Conference.
As a reader of the Partnerships in Clinical Trials blog, mention code XP1718BLOG when registering to join us in Sao Paulo for Partnerships in Clinical Trials Latin America to receive a discount of $100 off the current rate!
Would you like to guest blog on our site? Or send us feedback? Send an email to jpereira@iirusa.com.



.gif)
0 comments:
Post a Comment